Company Filing History:
Years Active: 2024-2025
Title: Kevin An: Innovator in Lipid Nanoparticle Technology
Introduction
Kevin An is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of lipid nanoparticle technology, holding 2 patents that showcase his innovative approach to enhancing drug delivery systems.
Latest Patents
Kevin An's latest patents focus on high sterol-containing lipid nanoparticles. The first patent provides a lipid nanoparticle comprising a nucleic acid cargo molecule, sterol or a derivative thereof present at elevated content, neutral lipid, an ionizable lipid, and a hydrophilic polymer-lipid conjugate present at a content between 0.5 and 3 mol %. Each mol % content is relative to the total lipid present in the lipid nanoparticle. This innovative formulation aims to improve the efficacy of nucleic acid delivery.
Career Highlights
Kevin An is currently associated with Nanovation Therapeutics Inc., where he continues to develop cutting-edge technologies in the field of nanomedicine. His work has the potential to revolutionize how therapeutic agents are delivered to target cells, enhancing treatment outcomes.
Collaborations
Kevin collaborates with talented professionals in his field, including Daniel Kurek and Jayesh Kulkarni. Their combined expertise fosters a creative environment that drives innovation and research forward.
Conclusion
Kevin An is a key figure in the advancement of lipid nanoparticle technology, with a focus on improving drug delivery systems. His contributions are paving the way for future innovations in the medical field.